RecruitingNCT05292235
Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
Sponsor
Chinese University of Hong Kong
Enrollment
2,000 participants
Start Date
Apr 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective data registry to assess the treatment outcomes and complications of different treatment approaches in our hospital clusters.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria1
- Patient at the age of 18 or above
Exclusion Criteria1
- Patient is unable to give consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05292235
Related Trials
Spinal Versus General Anesthesia in Open Simple Prostatectomy
NCT076434152 locations
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT0651114120 locations
Water Vapor Thermal Therapy Versus Ejaculation-Sparing Bipolar Transurethral Enucleation for Benign Prostatic Hyperplasia
NCT076488881 location
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NCT0684925820 locations
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
NCT076327421 location